Low molecular weight heparin vs placebo or no prophylaxis
Pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in pulmonary embolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization 2017 · Cochrane Headline outcomes onlyOR 0.5 [0.17, 1.47]5 studies · 2517 participantsLow